Идёт набор NCT04137549

Registry Study on "Control Nocturnal Hypertension to Reach the Target "

— Наблюдательное Nocturnal Hypertension

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают: Это наблюдательное исследование: исследуемое лечение участникам по протоколу не назначают.
Кому может быть актуально: Состояния в реестре: Nocturnal Hypertension. Базовые параметры: 50 лет — 79 лет · Все.
Что важно проверить: Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится: Китай
Следующий шаг: Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

Registry Study on "Control Nocturnal Hypertension to Reach the Target "（CONTROL-NHT）

Обзор

Ambulatory blood pressure monitoring (ABPM) is a major innovation in the history of hypertension diagnosis. In clinical practice, the most well established indication for using ABPM is to identify patients who have high BP readings in the office but normal readings during usual daily activities outside of this setting or vice versa, and to identify varying 24-h BP profiles. However, in recent years, there has been increasing interest in BP values during sleep, and nocturnal BP is now recognized to be superior to daytime BP in predicting fatal and nonfatal cardiovascular events (stroke, myocardial infarction, and cardiovascular death), especially in medicated patients. The current direction in the management of hypertension is toward earlier and lower BP control for 24 hours, including the nocturnal and morning periods. Therefore, it may be of great significance to pay attention to the management of nocturnal blood pressure so as to reduce the increased cardiovascular risks. Information of nocturnal hypertensive patients defined by ABPM was prospectively registered nationwide, and then to investigate whether there was difference in cardiovascular prognosis according to the control of ambulatory nocturnal blood pressure.

Первичные конечные точки

The occurrence time of fatal and non-fatal cardiovascular events. [Срок оценки: From date of enrollment until date of first documented event assessed up to 3 years]

Вторичные конечные точки (2)

The occurrence time of all-cause mortality. [Срок оценки: From date of enrollment until date of first documented event, assessed up to 3 years]
The occurrence time of fatal and nonfatal stroke. [Срок оценки: From date of enrollment until date of first documented event assessed up to 3 years]

Критерии участия

Критерии включения

Age 50-79 years old
Clinical diagnosed hypertension with the use of antihypertensive drugs
Nocturnal hypertension ( nocturnal systolic blood pressure ≥ 130 mmHg and/or nocturnal diastolic blood pressure ≥ 80 mmHg)
A 24-hour ambulatory blood pressure monitoring was performed with validated equipment.
Willing to provide information about disease history and blood biochemical test data within 6 months.
Sign the informed consent